Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![DigitalMoreco Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::437691517.png) DigitalMore.co 📱ดิจิตอลมอร์ [@DigitalMoreco](/creator/twitter/DigitalMoreco) on x 8030 followers
Created: 2025-07-16 02:28:54 UTC

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer 


![](https://pbs.twimg.com/media/Gv8gzwHXEAALiLj.png)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945309639249215572/c:line.svg)

**Related Topics**
[$9926hk](/topic/$9926hk)

[Post Link](https://x.com/DigitalMoreco/status/1945309639249215572)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

DigitalMoreco Avatar DigitalMore.co 📱ดิจิตอลมอร์ @DigitalMoreco on x 8030 followers Created: 2025-07-16 02:28:54 UTC

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

XX engagements

Engagements Line Chart

Related Topics $9926hk

Post Link

post/tweet::1945309639249215572
/post/tweet::1945309639249215572